What are the left atrial (LA) volume, LA area in the apical four-chamber (A4C) view, and LA area in the apical two-chamber (A2C) view, as well as the calculated stroke volume (SV), ejection fraction (EF), and cardiac index (CI) used to assess cardiac function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The left atrial (LA) volume measurements of 26.5 ml in the apical four-chamber view (A4C) and 17.0 ml in the apical two-chamber view (A2C) are within normal limits, suggesting no significant left atrial enlargement, as supported by the 2016 guidelines for the evaluation of left ventricular diastolic function by echocardiography 1. The stroke volume (SV) of 39.4 ml indicates the amount of blood pumped by the heart in each beat. The ejection fraction (EF) of 65.3% is within normal range (normal being 55-70%), suggesting good systolic function of the left ventricle, as indicated by the European Association of Cardiovascular Imaging 1. The cardiac index (CI) of 25.6 ml/m² represents the cardiac output adjusted for body surface area. These values collectively help assess cardiac performance, with the normal EF indicating adequate heart contractility. The LA volumes appear relatively small, which could be normal depending on the patient's body size and other clinical factors, as discussed in the context of left atrial function and its association with atrial arrhythmias 1. Medical professionals use these parameters to evaluate heart function, diagnose cardiac conditions, and guide treatment decisions for conditions like heart failure, valvular disease, or cardiomyopathy, taking into consideration the correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters 1. Key points to consider in the evaluation of left ventricular diastolic function include the assessment of annular e′ velocity, average E/e′ ratio, LA maximum volume index, and the presence of tricuspid regurgitation signal, as outlined in the recommendations for the evaluation of left ventricular diastolic function by echocardiography 1. In clinical practice, these guidelines and recommendations are essential for making informed decisions about patient care, prioritizing morbidity, mortality, and quality of life as outcomes.

From the Research

LA Volume and Calculations

  • The provided LA volume values are:
    • LA A4Cs: 26.5 ml
    • LA A2Cs: 17.0 ml
  • The calculated values are:
    • SV (A4C): 39.4 ml (Stroke Volume)
    • EF (A4C): 65.3% (Ejection Fraction)
    • CI (A4C): 25.6 ml/m' (Cardiac Index)

Assessment of Cardiac Structure and Function

  • According to 2, heart failure with preserved ejection fraction should be suspected in patients with typical symptoms and signs of chronic heart failure, and echocardiographic findings of normal ejection fraction with impaired diastolic function confirm the diagnosis.
  • 3 suggests that a more complete evaluation and understanding of left ventricular function in patients with heart failure requires a comprehensive assessment, incorporating measures of left and right ventricular function, left ventricular geometry, left atrial size, and valvular function.

Diagnosis of Diastolic Heart Failure

  • 4 found that objective measurement of LV diastolic function serves to confirm rather than establish the diagnosis of diastolic heart failure, and the diagnosis can be made without the measurement of parameters that reflect LV diastolic function.

Prognosis and Mortality

  • 5 states that presence and extent of coronary artery disease are strongly associated with all-cause mortality in patients with heart failure and reduced ejection fraction, and presence of CAD doubles excess mortality compared to a matched general population.

Ejection Fraction as a Diagnostic Tool

  • 6 discusses the pros and cons of using ejection fraction as a diagnostic and prognostic tool, and whether its ongoing use is justified in the context of newer markers of LV function and the sophisticated questions posed by modern cardiology.

Related Questions

What are the left atrial (LA) volume, LA area in the apical four-chamber (A4C) view, and LA area in the apical two-chamber (A2C) view, as well as the calculated stroke volume (SV), ejection fraction (EF), and cardiac index (CI) used to assess cardiac function?
What characterizes cardiac ejection fraction in various cardiac conditions?
What is the ejection fraction?
What is the most likely cause of symptoms in a patient with hypertension, fatigue, shortness of breath, and bilateral ankle edema, with an S4 gallop on cardiac exam?
Can a patient with a decreased ejection fraction, atrial fibrillation (AFib), and low cardiac output syndrome after mitral valve repair via thoracotomy, who is newly started on metoprolol (beta blocker) and apixaban (factor Xa inhibitor), experience a normal post-operative course with worsening fatigue and shortness of breath (dyspnea) symptoms?
What are the differential diagnoses for a cerebral aneurysm?
What is the treatment for an acute exacerbation of bronchiectasis?
What are the left atrial (LA) volume, LA area in the apical four-chamber (A4C) view, and LA area in the apical two-chamber (A2C) view, as well as the calculated stroke volume (SV), ejection fraction (EF), and cardiac index (CI) used to assess cardiac function?
What is the treatment for celiac disease (CD)?
What are the controversies surrounding the use of Prostate-Specific Antigen (PSA) in diagnosing prostate cancer?
How to document a 5mm x 5mm raised brown melanocytic nevus (mole) with no bleeding, circular in shape?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.